Analyses of markers related to apoptosis in NAFLD studies have shown an increase in AKT with a decrease in phosphate-AKT, increase in Bax, and increase in cleaved caspase-3 in the hepatic tissue [23, 24, 42]. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.